bibliographicCitation |
Ananthasubramaniam K, Weiss R, McNutt B, Klauke B, Feaheny K, Bukofzer S. A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease. Journal of Nuclear Cardiology. 2012 Jan 19;19(2):319–29. doi: 10.1007/s12350-011-9508-3. |